Evidence map›Paper›PMID 30098983›Full record

ArticleArchives of biochemistry and biophysics2018

Decarbamoylation of acetylcholinesterases is markedly slowed as carbamoyl groups increase in size.

Kunisi S Venkatasubban, Joseph L Johnson, Jamie L Thomas, Abdul Fauq, Bernadette Cusack, Terrone L Rosenberry

Open access · greenAbstract read
In one paragraph

Article in Archives of biochemistry and biophysics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Bioactive structures for inhibitors ofFuture medicinal chemistry · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kunisi S VenkatasubbanUniversity of North Florida, Department of Chemistry, Jacksonville, FL, 32224, USA.
Joseph L JohnsonMayo Clinic College of Medicine, Departments of Neuroscience and Pharmacology, Jacksonville, FL, 32224, USA.
Jamie L ThomasMayo Clinic College of Medicine, Departments of Neuroscience and Pharmacology, Jacksonville, FL, 32224, USA.
Abdul FauqMayo Clinic College of Medicine, Departments of Neuroscience and Pharmacology, Jacksonville, FL, 32224, USA.
Bernadette CusackMayo Clinic College of Medicine, Departments of Neuroscience and Pharmacology, Jacksonville, FL, 32224, USA.
Terrone L RosenberryMayo Clinic College of Medicine, Departments of Neuroscience and Pharmacology, Jacksonville, FL, 32224, USA. Electronic address: rosenberry@mayo.edu.
Mayo Clinic in Florida · USJacksonville College · USUniversity of North Florida · US

Funding

STRUCTURAL DISTINCTIONS AMONG ACETYLCHOLINESTERASESR01NS016577 · NINDS · MAYO CLINIC JACKSONVILLE · PI ROSENBERRY, TERRONE L · 1985 to 2005
$1.3M
Acetylcholinesterase Inhibition by FasciculinF32NS041828 · NINDS · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI JOHNSON, JOSEPH L · 2001 to 2002
$79k
NINDS NIH HHS F32 NS041828NINDS NIH HHS R01 NS016577
6 · The paper itself

Abstract

Carbamates are esters of substituted carbamic acids that react with acetylcholinesterase (AChE) by initially transferring the carbamoyl group to a serine residue in the enzyme active site accompanied by loss of the carbamate leaving group followed by hydrolysis of the carbamoyl enzyme. This hydrolysis, or decarbamoylation, is relatively slow, and half-lives of carbamoylated AChEs range from 4 min to more than 30 days. Therefore, carbamates are effective AChE inhibitors that have been developed as insecticides and as therapeutic agents. We show here, in contrast to a previous report, that decarbamoylation rate constants are independent of the leaving group for a series of carbamates with the same carbamoyl group. When the alkyl substituents on the carbamoyl group increased in size from N-monomethyl- to N,N-dimethyl-, N-ethyl-N-methyl-, or N,N-diethyl-, the decarbamoylation rate constants decreased by 4-, 70-, and 800-fold, respectively. We suggest that this relationship arises as a result of active site distortion, particularly in the acyl pocket of the active site. Furthermore, solvent deuterium oxide isotope effects for decarbamoylation decreased from 2.8 for N-monomethylcarbamoyl AChE to 1.1 for N,N-diethylcarbamoyl AChE, indicating a shift in the rate-limiting step from general acid-base catalysis to a likely conformational change in the distorted active site.

Indexed as

Protein CarbamylationAcetylcholinesteraseAnimalsCarbamatesCatalytic DomainCell LineDrosophilaEnzyme AssaysHumansKineticsAcetylcholinesteraseCarbamatesAcetylcholinesteraseAlzheimer's diseaseDecarbamoylation

Identifiers

PMID30098983
PMCPMC6204216
OpenAlexW2885448794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.